NewsBenzinga高盛维持对 Versigent 的“买入”评级,将目标价下调至 58 美元 高盛维持对 Versigent 的“买入”评级,将目标价下调至 58 美元 Benzinga 2026.10.06 09:35 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Belite Bio, Raises Price Target to $314 Applied Optoelectronics Stock Sinks Amid AI Outlook Fears Canaccord Genuity Maintains Buy on Enovix, Lowers Price Target to $2.5 Canaccord Genuity Maintains Buy on Intuitive Machines, Lowers Price Target to $38 Ex-Carlyle Executive Launches Asia Secondaries Firm as $3 Trillion Sits Locked in Private Funds 'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report
'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report